Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TaMoVac II: HIVIS DNA Vaccine with Electroporation
NCT01697007Phase 2Completed
- Sponsor
- Muhimbili University of Health and Allied Sciences
- Start
- Nov 2012
- Primary completion
- Dec 2014
- Modality
- Viral Vector Vaccines, DNA Vaccines
- Countries
- 2
01
Overview
A Phase 2 trial of HIVIS in human immunodeficiency virus infection (HIV), sponsored by Muhimbili University of Health and Allied Sciences. Started Nov 2012; status: completed.
02
Drugs
HIVIS
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01697007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01697007.